SPRC Financials: Scisparc Ltd AI Analysis

Home

Stock

SPRC

Financials

SPRC Financial

Scisparc Ltd

$4.35

-3.76%

$-0.16

At close: Mar 24, 16:00:00 GMT-4

$4.34

-0.11%

$0

Post-market: Mar 24, 16:24:06 GMT-4

Overview Forecast Earnings Dividends Financials

Key Stats

Prev.Close

$4.52

Open

$4.47

Day's Range

$4.21 - $4.5

52 week range

$3.6 - $94.5

Volume

11.5K

Avg.Volume

193.5K

Dividend yield

EPS (TTM)

-1.51

Market Cap

$2.4M

What is SPRC?

SciSparc Ltd. is a clinical stage pharmaceutical company, which focuses on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The firm is engaged in drug development programs based on repurposing a cannabinoid (Dronabinol): THX-110 for the treatment of Tourette syndrome (TS), for the treatment of Obstructive Sleep Apnea (OSA), and the treatment of Pain; THX-130 for the treatment of Mild Cognitive Impairment (MCI) and Traumatic Brain Injury (TBI); THX-150 for the treatment of infectious diseases; and THX-160 for the treatment of pain.



Features

AI Copilot for Stock & Crypto

Resources

Market

Income

Balance sheet

Cash flow

Annual

Quarterly

SPRC Income

Financials in millions USD. Fiscal year is February - January.

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	0	1	2	1	0	0
Revenue Growth (YoY)	--	-50%	100%	--	--	--
Cost of Revenue	0	0	0	0	--	--
Gross Profit	0	0	2	1	--	--
Selling, General & Admin	2	6	6	6	3	1
Research & Development	0	1	1	2	1	0
Operating Expenses	3	6	7	9	5	2
Other Non Operating Income (Expenses)	--	0	0	-1	0	0
Pretax Income	-9	-7	-5	-2	-5	-3
Income Tax Expense	0	0	0	0	--	--
Net Income	-9	-6	-5	-2	-5	-3
Net Income Growth	--	20%	150%	-60%	67%	-25%
Shares Outstanding (Diluted)	0.52	0.03	0	0	0	0
Shares Change (YoY)	--	1,300%	144%	125%	-94%	-77%
EPS (Diluted)	-17.94	-203.76	-2,370.37	-2,784.94	-13,785.71	-490.83
EPS Growth	--	-91%	-15%	-80%	2,709%	212%
Free Cash Flow	-1	-5	-5	-12	-5	-4
Free Cash Flow Per Share	--	--	--	--	--	--
Gross Margin	0%	0%	100%	100%	--	--
Operating Margin	0%	-500%	-250%	-800%	0%	0%
Profit Margin	0%	-600%	-250%	-200%	0%	0%
Free Cash Flow Margin	0%	-500%	-250%	-1,200%	0%	0%
EBITDA	-2	-5	-5	-8	-5	-2
EBITDA Margin	0%	-500%	-250%	-800%	0%	0%
D&A For EBITDA	0	0	0	0	0	0
EBIT	-2	-5	-5	-8	-5	-2
EBIT Margin	0%	-500%	-250%	-800%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	--	--

Follow-Up Questions

What are Scisparc Ltd's key financial statements?



According to the latest financial statement (Form-10K), Scisparc Ltd has a total asset of $10, Net loss of $-6

What are the key financial ratios for SPRC?



Scisparc Ltd's Current ratio is 5, has a Net margin is -600, sales per share of $32.46.

How is Scisparc Ltd's revenue broken down by segment or geography?



Scisparc Ltd largest revenue segment is Drug Development, at a revenue of 2,879,000 in the most earnings release.For geography, Israel is the primary market for Scisparc Ltd, at a revenue of 2,879,000.

Is Scisparc Ltd profitable?



no, according to the latest financial statements, Scisparc Ltd has a net loss of $-6

Does Scisparc Ltd have any liabilities?



yes, Scisparc Ltd has liability of 2

How many outstanding shares for Scisparc Ltd?



Scisparc Ltd has a total outstanding shares of 0.05

Scisparc Ltd (SPRC) Financial

SPRC Stock Price Chart